In this review, the clinical features of Parkinson's disease, both motor and non‐motor, are
described in the context of the progression of the disease. Also briefly discussed are the …

Parkinson's disease is the most common serious movement disorder in the world, affecting
about 1% of adults older than 60 years. The disease is attributed to selective loss of neurons …

Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many
as 1–2% of persons aged 60 years and older. With the aging of the population, the …

Accumulating evidence suggests that sporadic Parkinson's disease has a long prodromal
period during which several non‐motor features develop, in particular, impairment of …

Accumulating evidence suggests that sporadic Parkinson's disease (sPD) has a long
prodromal period during which several nonmotor features develop; in particular, impairment …

Pain is a nonmotor symptom that substantially affects the quality of life of at least one-third of
patients with Parkinson disease (PD). Interestingly, patients with PD frequently report …

Only a few years after the introduction of levodopa, the first descriptions of motor fluctuations
and dyskinesia related to dopaminergic therapy appeared. In PD, attention turned to their …

Objective: There is a wide range of autonomic symptoms (AS) in Parkinson disease (PD),
but the full spectrum has never been evaluated with a validated instrument and in …

Clinical signs frequently recognized in early phases of sporadic Parkinson's disease (PD)
may include autonomic dysfunctions and the experience of pain. Early disease-related …

Parkinson's disease (PD) is the second most common neurodegenerative disease after
Alzheimer's disease. Traditionally, attention has focused on the motor symptomatology of …